{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:36:46Z","timestamp":1790483806554,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00284-021-02396-x","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T14:03:01Z","timestamp":1614434581000},"page":"1099-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options"],"prefix":"10.1007","volume":"78","author":[{"given":"Arezoo","family":"Beig Parikhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoume","family":"Bazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Bamehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Fereshteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Salehi-Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-3217","authenticated-orcid":false,"given":"Arash","family":"Arashkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayhan","family":"Azadmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"issue":"11","key":"2396_CR1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2020.1490","volume":"323","author":"C del Rio","year":"2020","unstructured":"del Rio C, Malani PN (2020) 2019 Novel coronavirus\u2014important information for clinicians. JAMA 323(11):1039\u20131040","journal-title":"JAMA"},{"key":"2396_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.07.937862","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya AE (2020) Severe acute respiratory syndrome-related coronavirus\u2014the species and its viruses, a statement of the Coronavirus Study Group. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.07.937862","journal-title":"BioRxiv"},{"key":"2396_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","volume":"100","author":"VM Corman","year":"2018","unstructured":"Corman VM, Muth D, Niemeyer D, Drosten C (2018) Hosts and sources of endemic human coronaviruses. Adv Virus Res 100:163\u2013188","journal-title":"Adv Virus Res"},{"issue":"16","key":"2396_CR4","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1128\/JVI.00080-16","volume":"90","author":"NR Sexton","year":"2016","unstructured":"Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB, Denison MR (2016) Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens. J Virol 90(16):7415\u20137428","journal-title":"J Virol"},{"issue":"4","key":"2396_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418\u2013423","journal-title":"J Med Virol"},{"issue":"10","key":"2396_CR6","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7150\/ijbs.45123","volume":"16","author":"G Zhou","year":"2020","unstructured":"Zhou G, Zhao Q (2020) Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int J Biol Sci 16(10):1718","journal-title":"Int J Biol Sci"},{"key":"2396_CR7","volume-title":"Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 09 July 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 09 July 2020. World Health Organization, Geneva"},{"issue":"3","key":"2396_CR8","first-page":"2000044","volume":"25","author":"P Wu","year":"2020","unstructured":"Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT et al (2020) Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill Eur Commun Dis Bull 25(3):2000044","journal-title":"Euro Surveill Eur Commun Dis Bull"},{"key":"2396_CR9","doi-asserted-by":"publisher","unstructured":"Ganier C, Du-Harpur X, Harun N, Wan B, Arthurs C, Luscombe NM et al (2020) CD147 (BSG) but not ACE2 expression is detectable in vascular endothelial cells within single cell RNA sequencing datasets derived from multiple tissues in healthy individuals. bioRxiv. https:\/\/doi.org\/10.1101\/2020.05.29.123513","DOI":"10.1101\/2020.05.29.123513"},{"issue":"11","key":"2396_CR10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.2020.1623","volume":"323","author":"D Chang","year":"2020","unstructured":"Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CSD et al (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 323(11):1092\u20131093","journal-title":"JAMA"},{"issue":"4","key":"2396_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","volume":"92","author":"D Benvenuto","year":"2020","unstructured":"Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M (2020) The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol 92(4):455\u2013459","journal-title":"J Med Virol"},{"issue":"3","key":"2396_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"X Xu","year":"2020","unstructured":"Xu X, Chen P, Wang J, Feng J, Zhou H, Li X et al (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63(3):457\u2013460","journal-title":"Sci China Life Sci"},{"key":"2396_CR13","doi-asserted-by":"crossref","first-page":"104285","DOI":"10.1016\/j.meegid.2020.104285","volume":"82","author":"C Li","year":"2020","unstructured":"Li C, Yang Y, Ren L (2020) Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect Genet Evol 82:104285","journal-title":"Infect Genet Evol"},{"issue":"10","key":"2396_CR14","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JVI.03488-13","volume":"88","author":"CM Coleman","year":"2014","unstructured":"Coleman CM, Frieman MB (2014) Coronaviruses: important emerging human pathogens. J Virol 88(10):5209\u20135212","journal-title":"J Virol"},{"issue":"2","key":"2396_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13550280490280292","volume":"10","author":"S Navas-Mart\u00edn","year":"2004","unstructured":"Navas-Mart\u00edn S, Weiss SR (2004) Coronavirus replication and pathogenesis: implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol 10(2):75\u201385","journal-title":"J Neurovirol"},{"key":"2396_CR16","first-page":"1","volume-title":"Advances in virus research","author":"MMC Lai","year":"1997","unstructured":"Lai MMC, Cavanagh D (1997) The molecular biology of coronaviruses. In: Maramorosch K, Murphy FA, Shatkin AJ (eds) Advances in virus research, vol 48. Academic, Cambridge, pp 1\u2013100"},{"issue":"10","key":"2396_CR17","doi-asserted-by":"crossref","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","volume":"1866","author":"AAT Naqvi","year":"2020","unstructured":"Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A et al (2020) Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta Mol Basis Dis 1866(10):165878","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"2396_CR18","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cid\/ciaa410","volume":"71","author":"H Chu","year":"2020","unstructured":"Chu H, Chan JF-W, Wang Y, Yuen TT-T, Chai Y, Hou Y et al (2020) Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis 71(6):1400\u20131409","journal-title":"Clin Infect Dis"},{"key":"2396_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.31.929042","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, Mueller MA, Drosten C, P\u00f6hlmann S (2020) The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. https:\/\/doi.org\/10.1101\/2020.01.31.929042","journal-title":"BioRxiv"},{"issue":"36","key":"2396_CR20","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1073\/pnas.2010146117","volume":"117","author":"J Damas","year":"2020","unstructured":"Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M et al (2020) Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci USA 117(36):22311\u201322322","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2396_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","volume":"525","author":"Y Chen","year":"2020","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ (2020) Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 525(1):135\u2013140","journal-title":"Biochem Biophys Res Commun"},{"key":"2396_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Song L (2020) Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cell Mol Immunol 17:1\u20133","journal-title":"Cell Mol Immunol"},{"key":"2396_CR23","first-page":"179","volume-title":"Nidoviruses","author":"BG Hogue","year":"2008","unstructured":"Hogue BG, Machamer CE (2008) Coronavirus structural proteins and virus assembly. Nidoviruses. American Society of Microbiology, Washington, DC, pp 179\u2013200"},{"key":"2396_CR24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000513","author":"JK Yap","year":"2020","unstructured":"Yap JK, Moriyama M, Iwasaki A (2020) Inflammasomes and pyroptosis as therapeutic targets for COVID-19. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.2000513","journal-title":"J Immunol"},{"key":"2396_CR25","doi-asserted-by":"crossref","unstructured":"Yang M (2020) Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. Available at SSRN https:\/\/ssrn.com\/abstract=3527420","DOI":"10.2139\/ssrn.3527420"},{"issue":"7","key":"2396_CR26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","volume":"75","author":"AK Azkur","year":"2020","unstructured":"Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Br\u00fcggen MC et al (2020) Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 75(7):1564\u20131581","journal-title":"Allergy"},{"key":"2396_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41591-019-0740-8","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K et al (2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26:1\u20134","journal-title":"Nat Med"},{"issue":"1","key":"2396_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2020.09.013","volume":"183","author":"PF Ca\u00f1ete","year":"2020","unstructured":"Ca\u00f1ete PF, Vinuesa CG (2020) COVID-19 makes B cells forget, but T cells remember. Cell 183(1):13\u201315","journal-title":"Cell"},{"issue":"1","key":"2396_CR29","doi-asserted-by":"crossref","first-page":"1807836","DOI":"10.1080\/2162402X.2020.1807836","volume":"9","author":"C Melenotte","year":"2020","unstructured":"Melenotte C, Silvin A, Goubet A-G, Lahmar I, Dubuisson A, Zumla A et al (2020) Immune responses during COVID-19 infection. OncoImmunology 9(1):1807836","journal-title":"OncoImmunology"},{"key":"2396_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41577-019-0258-9","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, Wherry EJ (2020) T cell responses in patients with COVID-19. Nat Rev Immunol 20:1\u20138","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2396_CR31","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian\u2013Pac J Allergy Immunol 38(1):1\u20139","journal-title":"Asian\u2013Pac J Allergy Immunol"},{"key":"2396_CR32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X et al (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27:1451\u20131454","journal-title":"Cell Death Differ"},{"issue":"8","key":"2396_CR33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727\u2013733","journal-title":"N Engl J Med"},{"key":"2396_CR34","doi-asserted-by":"publisher","unstructured":"Meckiff BJ, Ram\u00edrez-Su\u00e1stegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, et al (2020) Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+ T cells. Available at SSRN https:\/\/doi.org\/10.2139\/ssrn.3641939","DOI":"10.2139\/ssrn.3641939"},{"key":"2396_CR35","doi-asserted-by":"crossref","first-page":"123771","DOI":"10.1016\/j.jhazmat.2020.123771","volume":"402","author":"B Feng","year":"2020","unstructured":"Feng B, Xu K, Gu S, Zheng S, Zou Q, Xu Y et al (2020) Multi-route transmission potential of SARS-CoV-2 in healthcare facilities. J Hazard Mater 402:123771","journal-title":"J Hazard Mater"},{"issue":"10223","key":"2396_CR36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395(10223):514\u2013523","journal-title":"Lancet"},{"issue":"3","key":"2396_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhin.2020.01.022","volume":"104","author":"G Kampf","year":"2020","unstructured":"Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 104(3):246\u2013251","journal-title":"J Hosp Infect"},{"key":"2396_CR38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fpubh.2020.00240","volume":"8","author":"S Yuan","year":"2020","unstructured":"Yuan S, Jiang S, Li Z-L (2020) Do humidity and temperature impact the spread of the novel coronavirus? Front Public Health 8:240","journal-title":"Front Public Health"},{"issue":"2","key":"2396_CR39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/20479700.2020.1755804","volume":"13","author":"S Lakshmi Priyadarsini","year":"2020","unstructured":"Lakshmi Priyadarsini S, Suresh M (2020) Factors influencing the epidemiological characteristics of pandemic COVID 19: a TISM approach. Int J Healthc Manag 13(2):89\u201398","journal-title":"Int J Healthc Manag"},{"key":"2396_CR40","doi-asserted-by":"publisher","unstructured":"Araban M, Karimy M, Mesri M, Armoon B, Koohestani HR, Azani H (2020) Epidemiological, clinical characteristics of coronavirus-infected disease (COVID-19) among sample of Iranian community: funding from survey in central of Iran. https:\/\/doi.org\/10.21203\/rs.3.rs-32797\/v1","DOI":"10.21203\/rs.3.rs-32797\/v1"},{"issue":"6","key":"2396_CR41","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z et al (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145(6):e20200702","journal-title":"Pediatrics"},{"key":"2396_CR42","doi-asserted-by":"crossref","first-page":"m627","DOI":"10.1136\/bmj.m627","volume":"368","author":"P Vetter","year":"2020","unstructured":"Vetter P, Eckerle I, Kaiser L (2020) COVID-19: a puzzle with many missing pieces. Br Med J 368:m627","journal-title":"Br Med J"},{"issue":"5","key":"2396_CR43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jmv.25711","volume":"92","author":"W Han","year":"2020","unstructured":"Han W, Quan B, Guo Y, Zhang J, Lu Y, Feng G et al (2020) The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. J Med Virol 92(5):461\u2013463","journal-title":"J Med Virol"},{"issue":"2","key":"2396_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bsheal.2020.03.004","volume":"2","author":"M D'Arienzo","year":"2020","unstructured":"D\u2019Arienzo M, Coniglio A (2020) Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. Biosaf Health 2(2):57\u201359","journal-title":"Biosaf Health"},{"issue":"6","key":"2396_CR45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jmv.25721","volume":"92","author":"Y Wang","year":"2020","unstructured":"Wang Y, Kang H, Liu X, Tong Z (2020) Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol 92(6):538\u2013539","journal-title":"J Med Virol"},{"key":"2396_CR46","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). In: Statpearls [internet]. StatPearls Publishing, Treasure Island"},{"issue":"5","key":"2396_CR47","doi-asserted-by":"crossref","first-page":"105955","DOI":"10.1016\/j.ijantimicag.2020.105955","volume":"55","author":"P Zhai","year":"2020","unstructured":"Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y (2020) The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 55(5):105955","journal-title":"Int J Antimicrob Agents"},{"issue":"42","key":"2396_CR48","first-page":"e2020006","volume":"2020","author":"Ryu S, Chun BC, Korean Society of Epidemiology 2019-nCoV Task Force Team. An interim review of the epidemiological characteristics of","year":"2019","unstructured":"Ryu S, Chun BC, Korean Society of Epidemiology 2019-nCoV Task Force Team. An interim review of the epidemiological characteristics of (2019) novel coronavirus. Epidemiol Health 2020(42):e2020006","journal-title":"Epidemiol Health"},{"key":"2396_CR49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jviromet.2018.12.010","volume":"265","author":"L Ma","year":"2019","unstructured":"Ma L, Zeng F, Cong F, Huang B, Huang R, Ma J et al (2019) Development of a SYBR green-based real-time RT-PCR assay for rapid detection of the emerging swine acute diarrhea syndrome coronavirus. J Virol Methods 265:66\u201370","journal-title":"J Virol Methods"},{"issue":"10","key":"2396_CR50","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/JCM.41.10.4521-4524.2003","volume":"41","author":"W Yam","year":"2003","unstructured":"Yam W, Chan K, Poon L, Guan Y, Yuen K, Seto W et al (2003) Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 41(10):4521\u20134524","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2396_CR51","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/diagnostics10050290","volume":"10","author":"P Han","year":"2020","unstructured":"Han P, Ivanovski S (2020) Saliva\u2014friend and foe in the COVID-19 outbreak. Diagnostics 10(5):290","journal-title":"Diagnostics"},{"key":"2396_CR52","first-page":"CD013705","volume":"8","author":"J Dinnes","year":"2020","unstructured":"Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S et al (2020) Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 8:CD013705","journal-title":"Cochrane Database Syst Rev"},{"key":"2396_CR53","unstructured":"Food and Drug Administration (2020) Coronavirus (COVID-19) update: FDA authorizes antigen test as first over-the-counter fully at-home diagnostic test for COVID-19. FDA News Release. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic. Accessed 26 Feb 2021"},{"key":"2396_CR54","volume-title":"Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. World Health Organization, Geneva"},{"issue":"1","key":"2396_CR55","first-page":"e34","volume":"8","author":"L Panahi","year":"2020","unstructured":"Panahi L, Amiri M, Pouy S (2020) Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review. Arch Acad Emerg Med 8(1):e34","journal-title":"Arch Acad Emerg Med"},{"key":"2396_CR56","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200432","author":"Y Fang","year":"2020","unstructured":"Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020200432","journal-title":"Radiology"},{"key":"2396_CR57","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200370","author":"F Pan","year":"2019","unstructured":"Pan F, Ye T, Sun P, Gui S, Liang B, Li L et al (2019) Time course of lung changes on chest CT during recovery from novel coronavirus (COVID-19) pneumonia. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020200370","journal-title":"Radiology"},{"key":"2396_CR58","doi-asserted-by":"publisher","unstructured":"Vengesai A, Midzi H, Kasambala M, Mutandadzi H, Mduluza-Jok T, Rusakaniko S et al (2020) A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. https:\/\/doi.org\/10.21203\/rs.3.rs-34638\/v2","DOI":"10.21203\/rs.3.rs-34638\/v2"},{"key":"2396_CR59","doi-asserted-by":"crossref","first-page":"m2516","DOI":"10.1136\/bmj.m2516","volume":"370","author":"ML Bastos","year":"2020","unstructured":"Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui L-P, Johnston JC et al (2020) Diagnostic accuracy of serological tests for COVID-19: systematic review and meta-analysis. BMJ 370:m2516","journal-title":"BMJ"},{"issue":"6","key":"2396_CR60","first-page":"E131","volume":"95","author":"BE Fan","year":"2020","unstructured":"Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB et al (2020) Hematologic parameters in patients with COVID-19 infection. Am J Hematol 95(6):E131\u2013E134","journal-title":"Am J Hematol"},{"key":"2396_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10074-6","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Sandri GBL et al (2020) Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatol Int. https:\/\/doi.org\/10.1007\/s12072-020-10074-6","journal-title":"Hepatol Int"},{"key":"2396_CR62","doi-asserted-by":"crossref","first-page":"106023","DOI":"10.1016\/j.rmed.2020.106023","volume":"169","author":"I Garcia-Oliv\u00e9","year":"2020","unstructured":"Garcia-Oliv\u00e9 I, Sintes H, Radua J, Capa JA, Rosell A (2020) D-dimer in patients infected with COVID-19 and suspected pulmonary embolism. Respir Med 169:106023","journal-title":"Respir Med"},{"key":"2396_CR63","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng K (2020) COVID-19: risk factors for severe disease and death. Br Med J 368:m1198","journal-title":"Br Med J"},{"issue":"6","key":"2396_CR64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/INF.0000000000002700","volume":"39","author":"P Zimmermann","year":"2020","unstructured":"Zimmermann P, Curtis N (2020) COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J 39(6):469\u2013477","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2396_CR65","first-page":"110","volume":"3","author":"N Sediqi","year":"2020","unstructured":"Sediqi N, Sediqi M (2020) A review on pathophysiology and pharmacological treatment of COVID-19. Int Innov Res Sci Stud 3(2):110\u2013122","journal-title":"Int Innov Res Sci Stud"},{"key":"2396_CR66","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.23.20026963","author":"W Cao","year":"2020","unstructured":"Cao W (2020) Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.23.20026963","journal-title":"medRxiv"},{"key":"2396_CR67","unstructured":"Fiorino S, Gallo C, Zippi M, Sabbatani S, Manfredi R, Moretti R et al (2020) COVID-19 perfect storm (Part II): role of vitamins as therapy or preventive strategy in aged people"},{"issue":"3","key":"2396_CR68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12519-020-00343-7","volume":"16","author":"K Shen","year":"2020","unstructured":"Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R et al (2020) Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement. World J Pediatr 16(3):223\u2013231","journal-title":"World J Pediatr"},{"key":"2396_CR69","doi-asserted-by":"publisher","unstructured":"Ohashi H, Watashi K, Saso W, Shionoya K, Iwanami S, Hirokawa T et al (2020) Multidrug treatment with nelfinavir and cepharanthine against COVID-19. bioRxiv. https:\/\/doi.org\/10.1101\/2020.04.14.039925","DOI":"10.1101\/2020.04.14.039925"},{"issue":"6","key":"2396_CR70","doi-asserted-by":"crossref","first-page":"105995","DOI":"10.1016\/j.ijantimicag.2020.105995","volume":"55","author":"P Luo","year":"2020","unstructured":"Luo P, Liu D, Li J (2020) Pharmacologic perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int J Antimicrob Agents 55(6):105995","journal-title":"Int J Antimicrob Agents"},{"key":"2396_CR71","unstructured":"FasterCures MI (2020) COVID-19 treatment and vaccine tracker. Milken Institute. https:\/\/covid-19tracker.milkeninstitute.org. Accessed 26 Feb 2021"},{"issue":"4","key":"2396_CR72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","volume":"76","author":"U Agrawal","year":"2020","unstructured":"Agrawal U, Raju R, Udwadia ZF (2020) Favipiravir: A new and emerging antiviral option in COVID-19. Med J Armed Forces India 76(4):370\u2013376","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"2396_CR73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.29121\/granthaalayah.v8.i4.2020.2","volume":"8","author":"DG Kramer","year":"2020","unstructured":"Kramer DG, Da Silva MJL, Da Silva GSE, De Moura AMMA, Junior GBC, De Sousa AM et al (2020) Favipiravir as a potential drug in the treatment of COVID-19. Int J Res GRANTHAALAYAH 8(4):7\u201312","journal-title":"Int J Res GRANTHAALAYAH"},{"issue":"1","key":"2396_CR74","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","volume":"81","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Lu Z, Xu T, Chen C, Yang G, Zha T et al (2020) Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19. J Infect 81(1):e21\u2013e23","journal-title":"J Infect"},{"key":"2396_CR75","first-page":"e79","volume":"35","author":"R Valizadeh","year":"2020","unstructured":"Valizadeh R, Dadashzadeh N, Zakeri R, Kellner SJ, Rahimi MM (2020) Drug therapy in hospitalized patients with very severe symptoms following COVID-19. Med Sci 35:e79","journal-title":"Med Sci"},{"issue":"1","key":"2396_CR76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","volume":"103","author":"P Luo","year":"2020","unstructured":"Luo P, Qiu L, Liu Y, Liu X-L, Zheng J-L, Xue H-Y et al (2020) Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg 103(1):69\u201372","journal-title":"Am J Trop Med Hyg"},{"key":"2396_CR77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","volume":"57","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 57:279\u2013283","journal-title":"J Crit Care"},{"issue":"4","key":"2396_CR78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/tde-2020-0035","volume":"11","author":"H Amawi","year":"2020","unstructured":"Amawi H, Abu Deiab GaI, Aljabali AA, Dua K, Tambuwala MM (2020) COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv 11(4):245\u2013268","journal-title":"Ther Deliv"},{"issue":"1","key":"2396_CR79","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 56(1):105949","journal-title":"Int J Antimicrob Agents"},{"key":"2396_CR80","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","volume":"178","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res 178:104787","journal-title":"Antivir Res"},{"issue":"3","key":"2396_CR81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271","journal-title":"Cell Res"},{"issue":"1","key":"2396_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03148-2","volume":"24","author":"FM van Haren","year":"2020","unstructured":"van Haren FM, Page C, Laffey JG, Artigas A, Camprubi-Rimblas M, Nunes Q et al (2020) Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care 24(1):1\u201311","journal-title":"Crit Care"},{"key":"2396_CR83","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z et al (2020) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol 214:108393","journal-title":"Clin Immunol"},{"key":"2396_CR84","unstructured":"National Library of Medivcine (US) (2020) Search result, 115 studies found for: interferon | COVID-19. Clinicaltrial.gov. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=COVID-19&term=interferon&cntry=&state=&city=&dist=&Search=Search"},{"key":"2396_CR85","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc066","author":"LH Calabrese","year":"2020","unstructured":"Calabrese LH, Lenfant T, Calabrese C (2020) Interferon therapy for COVID-19 and emerging infections: prospects and concerns. Clevel Clinic J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc066","journal-title":"Clevel Clinic J Med"},{"key":"2396_CR86","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01061-20","author":"E Davoudi-Monfared","year":"2020","unstructured":"Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L et al (2020) A randomized clinical trial of the efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01061-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"10238","key":"2396_CR87","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF-N Hung","year":"2020","unstructured":"Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y et al (2020) Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 395(10238):1695\u20131704","journal-title":"Lancet"},{"key":"2396_CR88","doi-asserted-by":"crossref","unstructured":"Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C et al (2020) Peginterferon-lambda for the treatment of COVID-19 in outpatients. medRxiv","DOI":"10.1101\/2020.11.09.20228098"},{"issue":"2","key":"2396_CR89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","volume":"21","author":"L Du","year":"2017","unstructured":"Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S (2017) MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets 21(2):131\u2013143","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"2396_CR90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","volume":"81","author":"Y Xie","year":"2020","unstructured":"Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W et al (2020) Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect 81(2):318\u2013356","journal-title":"J Infect"},{"issue":"8","key":"2396_CR91","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","volume":"2","author":"G Guaraldi","year":"2020","unstructured":"Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M et al (2020) Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol 2(8):e474\u2013e484","journal-title":"Lancet Rheumatol"},{"key":"2396_CR92","unstructured":"Liebich S. Potent SELEX aptamer-based therapeutic method for novel SARS-CoV2 virus disease (COVID-19)"},{"issue":"8","key":"2396_CR93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13543776.2020.1772231","volume":"30","author":"JAC Nascimento Junior","year":"2020","unstructured":"Nascimento Junior JAC, Santos AM, Quintans-J\u00fanior LJ, Walker CIB, Borges LP, Serafini MR (2020) SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review. Expert Opin Ther Pat 30(8):567\u2013579","journal-title":"Expert Opin Ther Pat"},{"key":"2396_CR94","first-page":"528","volume":"19","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Firdous SM, Nath A (2020) siRNA could be a potential therapy for COVID-19. EXCLI J 19:528","journal-title":"EXCLI J"},{"issue":"6494","key":"2396_CR95","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","volume":"368","author":"L Corey","year":"2020","unstructured":"Corey L, Mascola JR, Fauci AS, Collins FS (2020) A strategic approach to COVID-19 vaccine R&D. Science 368(6494):948\u2013950","journal-title":"Science"},{"key":"2396_CR96","unstructured":"World Health Organization (2020). Draft landscape of COVID-19 candidate vaccines. 29 December 2020. www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"issue":"7","key":"2396_CR97","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1586\/erv.09.43","volume":"8","author":"RL Roper","year":"2009","unstructured":"Roper RL, Rehm KE (2009) SARS vaccines: where are we? Expert Rev Vaccines 8(7):887\u2013898","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"2396_CR98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S (2009) The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat Rev Microbiol 7(3):226\u2013236","journal-title":"Nat Rev Microbiol"},{"key":"2396_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2183","author":"A Arashkia","year":"2020","unstructured":"Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M et al (2020) Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: state of the art and future prospects. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2183","journal-title":"Rev Med Virol"},{"issue":"2","key":"2396_CR100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines7020037","volume":"7","author":"MA Liu","year":"2019","unstructured":"Liu MA (2019) A comparison of plasmid DNA and mRNA as vaccine technologies. Vaccines 7(2):37","journal-title":"Vaccines"},{"issue":"3","key":"2396_CR101","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/jcm9030623","volume":"9","author":"J Pang","year":"2020","unstructured":"Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI-P et al (2020) Potential rapid diagnostics, vaccine and therapeutics for 2019 novel Coronavirus (2019-nCoV): a systematic review. J Clin Med 9(3):623","journal-title":"J Clin Med"},{"issue":"8","key":"2396_CR102","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","volume":"19","author":"D van Riel","year":"2020","unstructured":"van Riel D, de Wit E (2020) Next-generation vaccine platforms for COVID-19. Nat Mater 19(8):810\u2013812","journal-title":"Nat Mater"},{"issue":"1","key":"2396_CR103","first-page":"8","volume":"20","author":"A Mullard","year":"2020","unstructured":"Mullard A (2020) COVID-19 vaccines buoy hope. Nat Reviews Drug Discov 20(1):8","journal-title":"Nat Reviews Drug Discov"},{"key":"2396_CR104","unstructured":"Medicines and Healthcare Products Regulatory Agency (2020) Information for healthcare professionals on COVID-19 vaccine AstraZeneca. GOV.UK. https:\/\/www.gov.uk\/government\/publications\/regulatory-approval-of-covid-19-vaccine-astrazeneca\/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca. Accessed 26 Feb 2021"},{"key":"2396_CR105","doi-asserted-by":"crossref","unstructured":"Cyranoski D (2020) Arab nations first to approve Chinese COVID vaccine\u2014despite lack of public data. Nature. https:\/\/www.nature.com\/articles\/d41586-020-03563-z. Accessed 26 Feb 2021","DOI":"10.1038\/d41586-020-03563-z"},{"key":"2396_CR106","doi-asserted-by":"crossref","first-page":"m4576","DOI":"10.1136\/bmj.m4576","volume":"371","author":"E Mahase","year":"2020","unstructured":"Mahase E (2020) COVID-19: What do we know about the late stage vaccine candidates? Br Med J 371:m4576","journal-title":"Br Med J"},{"issue":"26","key":"2396_CR107","doi-asserted-by":"crossref","first-page":"14857","DOI":"10.1073\/pnas.2009637117","volume":"117","author":"R Zhang","year":"2020","unstructured":"Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ (2020) Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci USA 117(26):14857\u201314863","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-021-02396-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T07:35:18Z","timestamp":1671435318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-021-02396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1007\/s00284-021-02396-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}